Remote interstitial afterloading in cancer of the prostate: preliminary experience with the MicroSelectron.
Brachytherapy in the treatment of prostate cancer is an accepted modality. A considerable experience has been accrued using Iridium interstitial therapy. The major problem associated with this choice is that of radioprotection. We describe the first clinical use of the MicroSelectron, a remote afterloading device, in prostate brachytherapy. Twenty-six patients have now been treated using this system. Approximately 55 treatment interruptions with an average 5 hr increase in overall treatment time occurs. The initial problems associated with instituting remote afterloading to prostate brachytherapy and their solutions are discussed.
Porter
A T
AT
Dept. of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada.
Scrimger
J W
JW
Pocha
J S
JS
D001918:Brachytherapy / Q000295:instrumentation*; D006801:Humans; D007496:Iridium Radioisotopes / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011835:Radiation Protection / Q000295:instrumentation*
D007496:Iridium Radioisotopes